Bannai Hiroshi, Kambayashi Yoshinori, Tsujimura Koji, Nagashima Tsuyoshi, Takebe Naoya, Tominari Masataka, Nemoto Manabu, Ohta Minoru
Equine Research Institute, Japan Racing Association, Tochigi 329-0412, Japan.
Hidaka Training and Research Center, Japan Racing Association, Hokkaido 057-0171, Japan.
J Equine Sci. 2021;32(3):99-102. doi: 10.1294/jes.32.99. Epub 2021 Sep 6.
The antibody response in horses inoculated with 2 doses of a live equine herpesvirus type 1 vaccine with different vaccination intervals (1 to 3 months) was evaluated with regard to the persistence of virus-neutralizing (VN) antibodies. The durations for which the geometric mean VN titers were maintained significantly higher than those before the first vaccination (P<0.05) were up to 5 months in horses that received the vaccination with a 1-month interval (n=17) and 7 months for those that received it with a 2-month (n=17) or 3-month interval (n=14 or 17). The vaccination program with the 2-month interval was the most effective in maintaining VN antibodies for a long duration with the smallest gap of antibody decline between the first and second vaccinations.
对接种了2剂活的1型马疱疹病毒疫苗且接种间隔不同(1至3个月)的马匹的抗体反应,就病毒中和(VN)抗体的持久性进行了评估。对于接种间隔为1个月的马匹(n = 17),几何平均VN滴度维持显著高于首次接种前水平(P<0.05)的持续时间长达5个月;对于接种间隔为2个月(n = 17)或3个月(n = 14或17)的马匹,该持续时间为7个月。接种间隔为2个月的疫苗接种方案在长时间维持VN抗体方面最为有效,且首次和第二次接种之间抗体下降的差距最小。